HomeCompareSQBGQ vs MRK

SQBGQ vs MRK: Dividend Comparison 2026

SQBGQ yields 200000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SQBGQ wins by $4.911780474428384e+29M in total portfolio value
10 years
SQBGQ
SQBGQ
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full SQBGQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SQBGQ vs MRK

📍 SQBGQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSQBGQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SQBGQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SQBGQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SQBGQ
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SQBGQ beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SQBGQ + MRK for your $10,000?

SQBGQ: 50%MRK: 50%
100% MRK50/50100% SQBGQ
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SQBGQ
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SQBGQ buys
0
MRK buys
0
No recent congressional trades found for SQBGQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSQBGQMRK
Forward yield200000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.911780474428384e+29M$56.8K
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.911464459982279e+29M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SQBGQ vs MRK ($10,000, DRIP)

YearSQBGQ PortfolioSQBGQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,206$366.19+$20.00MSQBGQ
2$37,424,589,019$37,403,177,570.09$12,650$502.35+$37424.58MSQBGQ
3$65,416,215,188,220$65,376,170,877,969.18$14,407$694.19+$65416215.17MSQBGQ
4$106,868,230,495,008,900$106,798,235,144,757,520.00$16,585$967.82+$106868230494.99MSQBGQ
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$19,342$1,363.89+$163172871735896.84MSQBGQ
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$22,913$1,947.19+$232854599801468864.00MSQBGQ
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$27,662$2,823.89+$310570858137017057280.00MSQBGQ
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$34,159$4,173.35+$3.871481543016132e+23MSQBGQ
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$43,337$6,308.80+$4.510617497632811e+26MSQBGQ
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$56,776$9,798.13+$4.911780474428384e+29MSQBGQ

SQBGQ vs MRK: Complete Analysis 2026

SQBGQStock

Sequential Brands Group, Inc., together with its subsidiaries, owns various consumer brands in the active and lifestyle categories. The company licenses its brands for a range of product categories, including apparel, footwear, fashion accessories, and home goods. Its brands include Jessica Simpson, AND1, Avia, Joe's, GAIAM, Ellen Tracy, William Rast, Heelys, Caribbean Joe, DVS, and SPRI. The company promotes, markets, and licenses its brands through various distribution channels, including to retailers, wholesalers, and distributors in the United States and internationally. Sequential Brands Group, Inc. was incorporated in 2015 and is headquartered in New York, New York. On August 31, 2021, Sequential Brands Group, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on February 22, 2022.

Full SQBGQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SQBGQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SQBGQ vs SCHDSQBGQ vs JEPISQBGQ vs OSQBGQ vs KOSQBGQ vs MAINSQBGQ vs JNJSQBGQ vs ABBVSQBGQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.